SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

SunTrust Robinson Humphrey Maintains Buy on Genmab, Raises Price Target to $30

SunTrust Robinson Humphrey maintains Genmab (NASDAQ:GMAB) with a Buy and raises the price target from $28 to $30.

Benzinga · 05/07/2020 16:01

SunTrust Robinson Humphrey maintains Genmab (NASDAQ:GMAB) with a Buy and raises the price target from $28 to $30.